COMPREHENSIVE STUDY OF THE ANTIBODY-DRUG CONJUGATES MARKET: GROWTH TRENDS, COMPETITIVE DYNAMICS, AND FUTURE OUTLOOK

Antibody-drug conjugates are a groundbreaking innovation in cancer therapy, combining monoclonal antibodies with potent cytotoxic agents for highly targeted treatment. This approach enhances therapeutic efficacy while reducing systemic side effects, positioning antibody-drug conjugates as a transformative advancement in oncology. With cancer rates